NPI: 1780630327 · WYTHEVILLE, VA 24382 · Pain Medicine (Anesthesiology) Physician · NPI assigned 05/25/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 05/25/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,216 | $53K |
| 2019 | 7,844 | $242K |
| 2020 | 9,059 | $312K |
| 2021 | 10,911 | $440K |
| 2022 | 10,970 | $470K |
| 2023 | 19,664 | $804K |
| 2024 | 32,382 | $851K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16,086 | 14,306 | $1.12M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22,002 | 19,250 | $1.12M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3,878 | 3,520 | $245K |
| 87428 | 5,371 | 4,981 | $167K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,381 | 1,277 | $115K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5,508 | 5,061 | $66K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 888 | 805 | $62K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 559 | 540 | $43K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,338 | 1,205 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,773 | 1,482 | $21K |
| 20610 | 528 | 437 | $18K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 158 | 141 | $17K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,414 | 644 | $15K |
| 3074F | 2,605 | 2,376 | $11K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 313 | 278 | $10K |
| 36415 | Collection of venous blood by venipuncture | 5,590 | 4,999 | $9K |
| 3078F | 2,067 | 1,898 | $9K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 103 | 95 | $7K |
| 92552 | 271 | 261 | $7K | |
| 90688 | 570 | 527 | $7K | |
| 99460 | 147 | 119 | $6K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 97 | 91 | $6K |
| 81003 | 3,368 | 2,916 | $6K | |
| 90670 | 296 | 288 | $4K | |
| 96127 | 921 | 814 | $4K | |
| 87807 | 324 | 303 | $4K | |
| 92551 | 374 | 354 | $4K | |
| 3079F | 790 | 731 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 39 | 28 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 714 | 630 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 25 | 25 | $2K |
| 73562 | 72 | 66 | $2K | |
| 90677 | 60 | 57 | $2K | |
| 90680 | 154 | 150 | $2K | |
| 85018 | 774 | 752 | $2K | |
| 99173 | 653 | 628 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 36 | 26 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 32 | 30 | $1K |
| 73110 | 33 | 26 | $1K | |
| 73560 | 35 | 32 | $957.16 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 19 | 12 | $955.93 |
| 51798 | 144 | 123 | $941.88 | |
| 3077F | 165 | 147 | $923.10 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 25 | 24 | $838.57 |
| 90697 | 42 | 42 | $835.40 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 150 | 134 | $767.80 |
| 99383 | 17 | 15 | $724.35 | |
| 3080F | 140 | 129 | $660.50 | |
| 90698 | 60 | 56 | $622.34 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 14 | 13 | $564.84 |
| 3075F | 119 | 110 | $498.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 68 | 64 | $471.96 |
| 90656 | 39 | 38 | $440.79 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 702 | 572 | $410.43 |
| 90671 | 13 | 13 | $398.24 | |
| 73610 | 15 | 13 | $381.61 | |
| 81025 | 62 | 57 | $365.19 | |
| 90686 | 25 | 25 | $312.39 | |
| 83655 | 25 | 25 | $288.74 | |
| 82947 | 76 | 68 | $271.51 | |
| 99000 | 321 | 263 | $253.81 | |
| 80305 | 19 | 14 | $192.78 | |
| 3008F | 5,115 | 4,656 | $171.50 | |
| 90633 | 15 | 12 | $133.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 84 | 60 | $114.74 |
| 81002 | 19 | 17 | $47.96 | |
| 1036F | 2,279 | 2,041 | $25.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12 | 12 | $3.40 |
| 1126F | 649 | 589 | $0.00 | |
| 1125F | 48 | 43 | $0.00 | |
| 1160F | 1,218 | 1,088 | $0.00 |